Literature DB >> 9639218

Effects of postpartum corticosteroids in patients with HELLP syndrome.

O T Yalcin1, T Sener, H Hassa, S Ozalp, A Okur.   

Abstract

OBJECTIVE: To evaluate the effect of corticosteroid treatment on the postpartum recovery of parturients with HELLP syndrome.
METHOD: Thirty cases with HELLP syndrome were randomly assigned to a study or a control group, each including 15 patients. A total dose of 30 mg intravenous dexamethasone was given to the study group during the 36 h following the childbirth, while the control group did not receive any steroid medication. Arterial blood pressure, urine output, hematocrit ratio, platelet count, serum alanine and aspartate aminotransferases and uric acid levels were monitored during the first 48 h postpartum. The data were analyzed by unpaired t-test, chi2 or Fisher's exact tests. RESULT: Before the treatment, no significant difference was observed between the two groups. The study group showed statistically significant improvement in mean arterial blood pressure, mean serum aspartate aminotransferase level, mean urine volume per hour and mean platelet count (P < 0.05). Length of hospitalization was also shorter in the study group (P < 0.01).
CONCLUSION: Early postpartum high-dose corticosteroid treatment accelerates the recovery and shortens the hospitalization of the parturients with HELLP syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639218     DOI: 10.1016/s0020-7292(98)00036-8

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  7 in total

Review 1.  Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome.

Authors:  Timothy L Clenney; Anthony J Viera
Journal:  BMJ       Date:  2004-07-31

Review 2.  Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy.

Authors:  Douglas M Woudstra; Sue Chandra; G Justus Hofmeyr; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

3.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

4.  COHELLP: collaborative randomized controlled trial on corticosteroids in HELLP syndrome.

Authors:  Leila Katz; Melania Amorim; João P Souza; Samira M Haddad; José G Cecatti
Journal:  Reprod Health       Date:  2013-05-22       Impact factor: 3.223

Review 5.  The HELLP syndrome: clinical issues and management. A Review.

Authors:  Kjell Haram; Einar Svendsen; Ulrich Abildgaard
Journal:  BMC Pregnancy Childbirth       Date:  2009-02-26       Impact factor: 3.007

Review 6.  Prognostic Factors of the Efficacy of High-dose Corticosteroid Therapy in Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome During Pregnancy: A Meta-analysis.

Authors:  Li Yang; Chenchen Ren; Minhong Mao; Shihong Cui
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 7.  Corticosteroid Therapy for Management of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP) Syndrome: A Meta-Analysis.

Authors:  Minhong Mao; Chen Chen
Journal:  Med Sci Monit       Date:  2015-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.